Research & Development



  雲瑯微微搖搖頭,霍光立刻命號手吹號,召回李勇。   于是,陛下只好不分青紅皂白的將山東田氏勢力最大的三個郡的百姓以三抽一的方式,抽調來到河西四郡。夜夜橾天天橾b在线观看   劉徹擺擺手道︰“立據兒為太子是朕的決斷,不是你用力的結果。朕如果不同意,你累死都沒用。這一次,據兒還算是長了一點心思,居然知道西域地的好處,還知道來朕的面前討要。長進不少!就是眼界太狹窄了一些。”亚洲成av人片在线观看   甦稚咬著嘴唇,焦急的等待劉陵出現。   謝寧直愣愣的看著江充,江充低頭嘿嘿一笑,指著謝寧道︰“看破莫要說破。”国产亚洲精品在线视频   雲瑯點點頭道︰“我的涼州牧能當多久?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo